These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22040718)

  • 21. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial.
    Jeger RV; Brunner-La Rocca HP; Hunziker PR; Tsakiris DA; Kaiser CA; Pfisterer ME;
    Clin Ther; 2009 Dec; 31(12):2886-93. PubMed ID: 20110027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in percutaneous coronary intervention in patients with chronic kidney disease.
    Coats WC; Dellsperger KC
    Adv Perit Dial; 2010; 26():42-6. PubMed ID: 21348378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycoprotein IIb-IIIa antagonists in percutaneous coronary interventions and acute coronary syndromes.
    Ramanathan A; Kleiman NS
    Indian Heart J; 1998 Oct; 50 Suppl 1():45-56. PubMed ID: 9824907
    [No Abstract]   [Full Text] [Related]  

  • 25. Current concepts on coronary revascularization in diabetic patients.
    Roffi M; Angiolillo DJ; Kappetein AP
    Eur Heart J; 2011 Nov; 32(22):2748-57. PubMed ID: 21893486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
    Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Unstable angina].
    Ibuki C
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():234-9. PubMed ID: 17952997
    [No Abstract]   [Full Text] [Related]  

  • 28. The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.
    Di Monaco A; Sestito A
    Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1611-36. PubMed ID: 23161033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of stable coronary artery disease].
    Jacobshagen C; Hasenfuss G
    MMW Fortschr Med; 2009 Nov; 151(47):45-9; quiz 50. PubMed ID: 20037979
    [No Abstract]   [Full Text] [Related]  

  • 30. Interventional therapy for coronary artery disease.
    Shah PB; Lilly CM
    Am J Respir Crit Care Med; 2002 Sep; 166(6):791-6. PubMed ID: 12231486
    [No Abstract]   [Full Text] [Related]  

  • 31. The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous coronary intervention.
    Mayes CE; Kandzari DE; Goldschmidt-Clermont PJ; Phillips HR
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():36E-46E; quiz 47E. PubMed ID: 12668861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.
    Conti CR
    Clin Cardiol; 2008 Jul; 31(7):295-6. PubMed ID: 18636470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding the understanding of the treatment of chronic angina: a 21st century approach--part 1.
    Conti CR
    Clin Cardiol; 2008 Jun; 31(6):239-40. PubMed ID: 18543302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive pharmacotherapy before percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: the role of modulating inflammation.
    Kereiakes DJ
    Circulation; 2003 Oct; 108(16 Suppl 1):III22-7. PubMed ID: 14605016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.
    Aoki J; Lansky AJ; Mehran R; Moses J; Bertrand ME; McLaurin BT; Cox DA; Lincoff AM; Ohman EM; White HD; Parise H; Leon MB; Stone GW
    Circulation; 2009 Feb; 119(5):687-98. PubMed ID: 19171852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
    Mega JL; Hochman JS; Scirica BM; Murphy SA; Sloan S; McCabe CH; Merlini P; Morrow DA
    Circulation; 2010 Apr; 121(16):1809-17. PubMed ID: 20385930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
    Galli M; Maggioni AP; Vassanelli C; Tavazzi L
    Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.